247 related articles for article (PubMed ID: 10196362)
1. Polyglutamine-expanded androgen receptors form aggregates that sequester heat shock proteins, proteasome components and SRC-1, and are suppressed by the HDJ-2 chaperone.
Stenoien DL; Cummings CJ; Adams HP; Mancini MG; Patel K; DeMartino GN; Marcelli M; Weigel NL; Mancini MA
Hum Mol Genet; 1999 May; 8(5):731-41. PubMed ID: 10196362
[TBL] [Abstract][Full Text] [Related]
2. Effects of heat shock, heat shock protein 40 (HDJ-2), and proteasome inhibition on protein aggregation in cellular models of Huntington's disease.
Wyttenbach A; Carmichael J; Swartz J; Furlong RA; Narain Y; Rankin J; Rubinsztein DC
Proc Natl Acad Sci U S A; 2000 Mar; 97(6):2898-903. PubMed ID: 10717003
[TBL] [Abstract][Full Text] [Related]
3. Chaperone suppression of aggregation and altered subcellular proteasome localization imply protein misfolding in SCA1.
Cummings CJ; Mancini MA; Antalffy B; DeFranco DB; Orr HT; Zoghbi HY
Nat Genet; 1998 Jun; 19(2):148-54. PubMed ID: 9620770
[TBL] [Abstract][Full Text] [Related]
4. Polyglutamine length-dependent interaction of Hsp40 and Hsp70 family chaperones with truncated N-terminal huntingtin: their role in suppression of aggregation and cellular toxicity.
Jana NR; Tanaka M; Wang Gh; Nukina N
Hum Mol Genet; 2000 Aug; 9(13):2009-18. PubMed ID: 10942430
[TBL] [Abstract][Full Text] [Related]
5. Polyglutamine protein aggregation and toxicity are linked to the cellular stress response.
Cowan KJ; Diamond MI; Welch WJ
Hum Mol Genet; 2003 Jun; 12(12):1377-91. PubMed ID: 12783846
[TBL] [Abstract][Full Text] [Related]
6. Molecular chaperones enhance the degradation of expanded polyglutamine repeat androgen receptor in a cellular model of spinal and bulbar muscular atrophy.
Bailey CK; Andriola IF; Kampinga HH; Merry DE
Hum Mol Genet; 2002 Mar; 11(5):515-23. PubMed ID: 11875046
[TBL] [Abstract][Full Text] [Related]
7. Chaperones Hsp70 and Hsp40 suppress aggregate formation and apoptosis in cultured neuronal cells expressing truncated androgen receptor protein with expanded polyglutamine tract.
Kobayashi Y; Kume A; Li M; Doyu M; Hata M; Ohtsuka K; Sobue G
J Biol Chem; 2000 Mar; 275(12):8772-8. PubMed ID: 10722721
[TBL] [Abstract][Full Text] [Related]
8. Ubiquitin/proteasome system.
Magnani M
Nat Biotechnol; 2000 Aug; 18(8):807. PubMed ID: 10932130
[No Abstract] [Full Text] [Related]
9. Transglutaminase potentiates ligand-dependent proteasome dysfunction induced by polyglutamine-expanded androgen receptor.
Mandrusiak LM; Beitel LK; Wang X; Scanlon TC; Chevalier-Larsen E; Merry DE; Trifiro MA
Hum Mol Genet; 2003 Jul; 12(13):1497-506. PubMed ID: 12812978
[TBL] [Abstract][Full Text] [Related]
10. Aggregation of huntingtin in yeast varies with the length of the polyglutamine expansion and the expression of chaperone proteins.
Krobitsch S; Lindquist S
Proc Natl Acad Sci U S A; 2000 Feb; 97(4):1589-94. PubMed ID: 10677504
[TBL] [Abstract][Full Text] [Related]
11. Proteasome inhibition in oxidative stress neurotoxicity: implications for heat shock proteins.
Ding Q; Keller JN
J Neurochem; 2001 May; 77(4):1010-7. PubMed ID: 11359866
[TBL] [Abstract][Full Text] [Related]
12. Aggregate formation inhibits proteasomal degradation of polyglutamine proteins.
Verhoef LG; Lindsten K; Masucci MG; Dantuma NP
Hum Mol Genet; 2002 Oct; 11(22):2689-700. PubMed ID: 12374759
[TBL] [Abstract][Full Text] [Related]
13. Involvement of the ubiquitin-proteasome pathway and molecular chaperones in oculopharyngeal muscular dystrophy.
Abu-Baker A; Messaed C; Laganiere J; Gaspar C; Brais B; Rouleau GA
Hum Mol Genet; 2003 Oct; 12(20):2609-23. PubMed ID: 12944420
[TBL] [Abstract][Full Text] [Related]
14. A C619Y mutation in the human androgen receptor causes inactivation and mislocalization of the receptor with concomitant sequestration of SRC-1 (steroid receptor coactivator 1).
Nazareth LV; Stenoien DL; Bingman WE; James AJ; Wu C; Zhang Y; Edwards DP; Mancini M; Marcelli M; Lamb DJ; Weigel NL
Mol Endocrinol; 1999 Dec; 13(12):2065-75. PubMed ID: 10598582
[TBL] [Abstract][Full Text] [Related]
15. Proteasome degrades soluble expanded polyglutamine completely and efficiently.
Michalik A; Van Broeckhoven C
Neurobiol Dis; 2004 Jun; 16(1):202-11. PubMed ID: 15207277
[TBL] [Abstract][Full Text] [Related]
16. [Development of therapeutics for spinal and bulbar muscular atrophy (SBMA)].
Sobue G
Rinsho Shinkeigaku; 2003 Nov; 43(11):909-11. PubMed ID: 15152501
[TBL] [Abstract][Full Text] [Related]
17. Hsp105alpha suppresses the aggregation of truncated androgen receptor with expanded CAG repeats and cell toxicity.
Ishihara K; Yamagishi N; Saito Y; Adachi H; Kobayashi Y; Sobue G; Ohtsuka K; Hatayama T
J Biol Chem; 2003 Jul; 278(27):25143-50. PubMed ID: 12714591
[TBL] [Abstract][Full Text] [Related]
18. Evidence for proteasome involvement in polyglutamine disease: localization to nuclear inclusions in SCA3/MJD and suppression of polyglutamine aggregation in vitro.
Chai Y; Koppenhafer SL; Shoesmith SJ; Perez MK; Paulson HL
Hum Mol Genet; 1999 Apr; 8(4):673-82. PubMed ID: 10072437
[TBL] [Abstract][Full Text] [Related]
19. Glucocorticoid modulation of androgen receptor nuclear aggregation and cellular toxicity is associated with distinct forms of soluble expanded polyglutamine protein.
Welch WJ; Diamond MI
Hum Mol Genet; 2001 Dec; 10(26):3063-74. PubMed ID: 11751688
[TBL] [Abstract][Full Text] [Related]
20. The ubiquitin-related BAG-1 provides a link between the molecular chaperones Hsc70/Hsp70 and the proteasome.
Lüders J; Demand J; Höhfeld J
J Biol Chem; 2000 Feb; 275(7):4613-7. PubMed ID: 10671488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
